Back to Journals » ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research
Editor-in-Chief: Professor Giorgio Colombo
An international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (1032)
- Volume 18, 2026 (49)
- Volume 17, 2025 (74)
- Volume 16, 2024 (62)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Medical Claim Costs of Facioscapulohumeral Muscular Dystrophy in the United States
Hill AA, Kinoshita J, Deypalan MN, Kolocha M, Hung M, Hon E, Sarraille W, Winegarden W, Ghanjanasak T, Arjomand J
ClinicoEconomics and Outcomes Research 2026, 18:576729
Published Date: 16 June 2026
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs
Perrone V, Innao V, Mazzoni S, Cappuccilli M, Andretta M, Bartolini F, Chinellato A, Dell’Orco S, Ferrante F, Lombardi R, Pagliaro R, Ubertazzo L, Valpondi P, Degli Esposti L
ClinicoEconomics and Outcomes Research 2026, 18:598572
Published Date: 16 June 2026
Total Laboratory Automation for Microbiology Activities: An HTA Analysis in an Italian Laboratory Setting
Foglia E, Garagiola E, Ferrario L, Adorisio E, Gagliardi G, Lenoci FD
ClinicoEconomics and Outcomes Research 2026, 18:597703
Published Date: 15 June 2026
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
Ghetti G, Castello L, Odonde LA, De Fazio S, Stella A, Bruno A, Marchionne E, Bonifacio M
ClinicoEconomics and Outcomes Research 2026, 18:599644
Published Date: 12 June 2026
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
Abu-Shraie N, Al-Sheikh A, Alharbi I, Alanizy L, Alshraim M, Khoshhal SI, AlSalman SA, Alrumaih A, Fasseeh AN, Elezbawy B, Abaza N, Semida A, George M, Amin S, Binamer Y
ClinicoEconomics and Outcomes Research 2026, 18:604093
Published Date: 11 June 2026